MedCity News January 4, 2022
Health analytics firm Aetion has acquired Replica Analytics, a company that specializes in synthetic data. Aetion said Replica will enable it to analyze previously inaccessible data while maintaining privacy and integrity of the original source data.
Aetion, a health analytics firm that serves entities across the life sciences spectrum, is building up its capabilities with the acquisition of a Replica Analytics, a company that uses artificial intelligence to generate its data.
New York-based Aetion provides insights based on real-world evidence. Its Aetion Evidence Platform analyzes data from the real world to assess the safety, efficacy, and value of drugs. Drug and medical device developers use those insights to guide development and commercialization of their products. For payers, the analysis contributes...
Today's Sponsors
Today's Sponsor